What's in Southampton Healthcare, Inc.'s pipeline?

Southampton Healthcare, Inc. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Southampton Healthcare, Inc.'s portfolio?

Top competitors by shared drug class: Fundacion SEIMC-GESIDA, University of California, San Francisco.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/southampton-healthcare-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Southampton Healthcare, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Southampton Healthcare, Inc. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Biktarvy Tab	Biktarvy Tab	marketed	Antiretroviral combination therapy (integrase inhibitor + nucleoside/nucleotide reverse transcriptase inhibitors)	HIV integrase, HIV reverse transcriptase, CCR5 co-receptor	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Fundacion SEIMC-GESIDA · 1 shared drug class
University of California, San Francisco · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Southampton Healthcare, Inc.:

Cite this brief

Drug Landscape (2026). Southampton Healthcare, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/southampton-healthcare-inc. Accessed 2026-05-18.